Cepheid-IMPACT-2023-CID-Respiratory-Prof-Fourati-Case-Study-CE-IVD-3318-French.pdf
IVD TYPE
Ref. 3318-01F
French
Cepheid-CID-Respiratory-CWPS Infographic-Case-Study-CE-IVD-3305-English.pdf
Produits
IVD TYPE
Ref. 3305-01
English
Cepheid-Bastiste-Interview-Case-Study-CE-IVD-3301-French.pdf
IVD TYPE
Ref. 3301-01
French
Cepheid-Corporate-Frost And Sullivan White Paper_Sars-Cov-2 Diagnostics_Leveraging A Point-Of-Care Testing In Next-Step Strategy-White Paper-US-IVD-French.pdf
French
Cepheid-Corporate-Frost And Sullivan White Paper_Sars-Cov-2 Diagnostics_Leveraging A Point-Of-Care Testing In Next-Step Strategy-White Paper-US-IVD-Italian.pdf
Italian
Cepheid-Corporate-Frost And Sullivan White Paper_Sars-Cov-2 Diagnostics_Leveraging A Point-Of-Care Testing In Next-Step Strategy-White Paper-US-IVD-Polish.pdf
Polish
Cepheid-Corporate-Frost And Sullivan White Paper_Sars-Cov-2 Diagnostics_Leveraging A Point-Of-Care Testing In Next-Step Strategy-White Paper-US-IVD-Spanish.pdf
Spanish
Cepheid-Corporate-Frost And Sullivan White Paper_Sars-Cov-2 Diagnostics_Leveraging A Point-Of-Care Testing In Next-Step Strategy-White Paper-US-IVD-German.pdf
German
Cepheid-Corporate-Frost And Sullivan White Paper_Sars-Cov-2 Diagnostics_Leveraging A Point-Of-Care Testing In Next-Step Strategy-White Paper-US-IVD-Portuguese.pdf
Portuguese
Cepheid-Corporate-Frost And Sullivan White Paper_Sars-Cov-2 Diagnostics_Leveraging A Point-Of-Care Testing In Next-Step Strategy-White Paper-US-IVD-English.pdf
English